Oral CorticoSteroid sparing with biologics in severe asthma:: A remark of the Severe Asthma Network in Italy (SANI)

G.W. Canonica; F. Blasi; P. Paggiaro; G. Senna; G. Passalacqua; A. Spanevello; S. Aliberti; D. Bagnasco; M. Bonavia; M. Bonini; L. Brussino; C. Bucca; M.F. Caiaffa; C. Calabrese; G. Camiciottoli; M. Caminati; G.E. Carpagnano; C. Caruso; S. Centanni; M.E. Conte; A.G. Corsico; L. Cosmi; M.T. Costantino; N. Crimi; S. D'Alò; M. D'Amato; S. Del Giacco; A. Farsi; E. Favero; M.P. Foschino Barbaro; G. Guarnieri; G. Guida; M. Latorre; S. Lo Cicero; C. Lombardi; L. Macchia; F. Mazza; F. Menzella; M. Milanese; M. Montagni; P. Montuschi; E. Nucera; R. Parente; V. Patella; G. Pelaia; L. Pini; F. Puggioni; L. Ricciardi; F.L.M. Ricciardolo; L. Richeldi; E. Ridolo; G. Rolla; P. Santus; N. Scichilone; G. Spadaro; A. Vianello; V. Viviano; M.R. Yacoub; M.C. Zappa; E. Heffler; SANI (Severe Asthma Network Italy)

doi:10.1016/j.waojou.2020.100464

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

G.W. Canonica, F. Blasi, P. Paggiaro, G. Senna, G. Passalacqua, A. Spanevello, S. Aliberti, D. Bagnasco, M. Bonavia, M. Bonini, L. Brussino, C. Bucca, M.F. Caiaffa, C. Calabrese, G. Camiciottoli, M. Caminati, G.E. Carpagnano, C. Caruso, S. Centanni, M.E. ConteA.G. Corsico, L. Cosmi, M.T. Costantino, N. Crimi, S. D'Alò, M. D'Amato, S. Del Giacco, A. Farsi, E. Favero, M.P. Foschino Barbaro, G. Guarnieri, G. Guida, M. Latorre, S. Lo Cicero, C. Lombardi, L. Macchia, F. Mazza, F. Menzella, M. Milanese, M. Montagni, P. Montuschi, E. Nucera, R. Parente, V. Patella, G. Pelaia, L. Pini, F. Puggioni, L. Ricciardi, F.L.M. Ricciardolo, L. Richeldi, E. Ridolo, G. Rolla, P. Santus, N. Scichilone, G. Spadaro, A. Vianello, V. Viviano, M.R. Yacoub, M.C. Zappa, E. Heffler, SANI (Severe Asthma Network Italy)

Research output: Contribution to journal › Article › peer-review

Abstract

According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored all alternatives currently available for a large part of severe asthmatics. © 2020 The Authors

Original language	English
Article number	100464
Journal	World Allergy Organization Journal
Volume	13
Issue number	10
DOIs	https://doi.org/10.1016/j.waojou.2020.100464
Publication status	Published - 2020

Access to Document

10.1016/j.waojou.2020.100464

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85091219259&doi=10.1016%2fj.waojou.2020.100464&partnerID=40&md5=ed8165eca34dcc53d11dcbfebb6f8783

Fingerprint Dive into the research topics of 'Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)'. Together they form a unique fingerprint.

Cite this

Canonica, G. W., Blasi, F., Paggiaro, P., Senna, G., Passalacqua, G., Spanevello, A., Aliberti, S., Bagnasco, D., Bonavia, M., Bonini, M., Brussino, L., Bucca, C., Caiaffa, M. F., Calabrese, C., Camiciottoli, G., Caminati, M., Carpagnano, G. E., Caruso, C., Centanni, S., ... Italy), SANI. S. A. N. (2020). Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI). World Allergy Organization Journal, 13(10), [100464]. https://doi.org/10.1016/j.waojou.2020.100464

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI). / Canonica, G.W.; Blasi, F.; Paggiaro, P.; Senna, G.; Passalacqua, G.; Spanevello, A.; Aliberti, S.; Bagnasco, D.; Bonavia, M.; Bonini, M.; Brussino, L.; Bucca, C.; Caiaffa, M.F.; Calabrese, C.; Camiciottoli, G.; Caminati, M.; Carpagnano, G.E.; Caruso, C.; Centanni, S.; Conte, M.E.; Corsico, A.G.; Cosmi, L.; Costantino, M.T.; Crimi, N.; D'Alò, S.; D'Amato, M.; Del Giacco, S.; Farsi, A.; Favero, E.; Foschino Barbaro, M.P.; Guarnieri, G.; Guida, G.; Latorre, M.; Lo Cicero, S.; Lombardi, C.; Macchia, L.; Mazza, F.; Menzella, F.; Milanese, M.; Montagni, M.; Montuschi, P.; Nucera, E.; Parente, R.; Patella, V.; Pelaia, G.; Pini, L.; Puggioni, F.; Ricciardi, L.; Ricciardolo, F.L.M.; Richeldi, L.; Ridolo, E.; Rolla, G.; Santus, P.; Scichilone, N.; Spadaro, G.; Vianello, A.; Viviano, V.; Yacoub, M.R.; Zappa, M.C.; Heffler, E.; Italy), SANI (Severe Asthma Network.

In: World Allergy Organization Journal, Vol. 13, No. 10, 100464, 2020.

Research output: Contribution to journal › Article › peer-review

Canonica, GW , Blasi, F, Paggiaro, P, Senna, G, Passalacqua, G, Spanevello, A , Aliberti, S, Bagnasco, D, Bonavia, M, Bonini, M, Brussino, L, Bucca, C, Caiaffa, MF, Calabrese, C, Camiciottoli, G, Caminati, M, Carpagnano, GE, Caruso, C, Centanni, S, Conte, ME, Corsico, AG, Cosmi, L, Costantino, MT, Crimi, N, D'Alò, S, D'Amato, M, Del Giacco, S, Farsi, A, Favero, E, Foschino Barbaro, MP, Guarnieri, G, Guida, G, Latorre, M, Lo Cicero, S , Lombardi, C, Macchia, L, Mazza, F, Menzella, F, Milanese, M, Montagni, M, Montuschi, P , Nucera, E, Parente, R, Patella, V, Pelaia, G, Pini, L, Puggioni, F, Ricciardi, L, Ricciardolo, FLM, Richeldi, L, Ridolo, E, Rolla, G, Santus, P, Scichilone, N, Spadaro, G, Vianello, A, Viviano, V, Yacoub, MR, Zappa, MC, Heffler, E & Italy), SANISAN 2020, 'Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)', World Allergy Organization Journal, vol. 13, no. 10, 100464. https://doi.org/10.1016/j.waojou.2020.100464

Canonica, G.W. ; Blasi, F. ; Paggiaro, P. ; Senna, G. ; Passalacqua, G. ; Spanevello, A. ; Aliberti, S. ; Bagnasco, D. ; Bonavia, M. ; Bonini, M. ; Brussino, L. ; Bucca, C. ; Caiaffa, M.F. ; Calabrese, C. ; Camiciottoli, G. ; Caminati, M. ; Carpagnano, G.E. ; Caruso, C. ; Centanni, S. ; Conte, M.E. ; Corsico, A.G. ; Cosmi, L. ; Costantino, M.T. ; Crimi, N. ; D'Alò, S. ; D'Amato, M. ; Del Giacco, S. ; Farsi, A. ; Favero, E. ; Foschino Barbaro, M.P. ; Guarnieri, G. ; Guida, G. ; Latorre, M. ; Lo Cicero, S. ; Lombardi, C. ; Macchia, L. ; Mazza, F. ; Menzella, F. ; Milanese, M. ; Montagni, M. ; Montuschi, P. ; Nucera, E. ; Parente, R. ; Patella, V. ; Pelaia, G. ; Pini, L. ; Puggioni, F. ; Ricciardi, L. ; Ricciardolo, F.L.M. ; Richeldi, L. ; Ridolo, E. ; Rolla, G. ; Santus, P. ; Scichilone, N. ; Spadaro, G. ; Vianello, A. ; Viviano, V. ; Yacoub, M.R. ; Zappa, M.C. ; Heffler, E. ; Italy), SANI (Severe Asthma Network. / Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI). In: World Allergy Organization Journal. 2020 ; Vol. 13, No. 10.

@article{169160196acf47ba84ce1155e91f4c3b,

title = "Oral CorticoSteroid sparing with biologics in severe asthma:: A remark of the Severe Asthma Network in Italy (SANI)",

abstract = "According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored all alternatives currently available for a large part of severe asthmatics. {\textcopyright} 2020 The Authors",

author = "G.W. Canonica and F. Blasi and P. Paggiaro and G. Senna and G. Passalacqua and A. Spanevello and S. Aliberti and D. Bagnasco and M. Bonavia and M. Bonini and L. Brussino and C. Bucca and M.F. Caiaffa and C. Calabrese and G. Camiciottoli and M. Caminati and G.E. Carpagnano and C. Caruso and S. Centanni and M.E. Conte and A.G. Corsico and L. Cosmi and M.T. Costantino and N. Crimi and S. D'Al{\`o} and M. D'Amato and {Del Giacco}, S. and A. Farsi and E. Favero and {Foschino Barbaro}, M.P. and G. Guarnieri and G. Guida and M. Latorre and {Lo Cicero}, S. and C. Lombardi and L. Macchia and F. Mazza and F. Menzella and M. Milanese and M. Montagni and P. Montuschi and E. Nucera and R. Parente and V. Patella and G. Pelaia and L. Pini and F. Puggioni and L. Ricciardi and F.L.M. Ricciardolo and L. Richeldi and E. Ridolo and G. Rolla and P. Santus and N. Scichilone and G. Spadaro and A. Vianello and V. Viviano and M.R. Yacoub and M.C. Zappa and E. Heffler and Italy), {SANI (Severe Asthma Network}",

note = "Export Date: 8 December 2020",

year = "2020",

doi = "10.1016/j.waojou.2020.100464",

language = "English",

volume = "13",

journal = "World Allergy Organization Journal",

issn = "1939-4551",

publisher = "Lippincott Williams and Wilkins",

number = "10",

}

TY - JOUR

T1 - Oral CorticoSteroid sparing with biologics in severe asthma:

T2 - A remark of the Severe Asthma Network in Italy (SANI)

AU - Canonica, G.W.

AU - Blasi, F.

AU - Paggiaro, P.

AU - Senna, G.

AU - Passalacqua, G.

AU - Spanevello, A.

AU - Aliberti, S.

AU - Bagnasco, D.

AU - Bonavia, M.

AU - Bonini, M.

AU - Brussino, L.

AU - Bucca, C.

AU - Caiaffa, M.F.

AU - Calabrese, C.

AU - Camiciottoli, G.

AU - Caminati, M.

AU - Carpagnano, G.E.

AU - Caruso, C.

AU - Centanni, S.

AU - Conte, M.E.

AU - Corsico, A.G.

AU - Cosmi, L.

AU - Costantino, M.T.

AU - Crimi, N.

AU - D'Alò, S.

AU - D'Amato, M.

AU - Del Giacco, S.

AU - Farsi, A.

AU - Favero, E.

AU - Foschino Barbaro, M.P.

AU - Guarnieri, G.

AU - Guida, G.

AU - Latorre, M.

AU - Lo Cicero, S.

AU - Lombardi, C.

AU - Macchia, L.

AU - Mazza, F.

AU - Menzella, F.

AU - Milanese, M.

AU - Montagni, M.

AU - Montuschi, P.

AU - Nucera, E.

AU - Parente, R.

AU - Patella, V.

AU - Pelaia, G.

AU - Pini, L.

AU - Puggioni, F.

AU - Ricciardi, L.

AU - Ricciardolo, F.L.M.

AU - Richeldi, L.

AU - Ridolo, E.

AU - Rolla, G.

AU - Santus, P.

AU - Scichilone, N.

AU - Spadaro, G.

AU - Vianello, A.

AU - Viviano, V.

AU - Yacoub, M.R.

AU - Zappa, M.C.

AU - Heffler, E.

AU - Italy), SANI (Severe Asthma Network

N1 - Export Date: 8 December 2020

PY - 2020

Y1 - 2020

N2 - According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored all alternatives currently available for a large part of severe asthmatics. © 2020 The Authors

AB - According to the data derived from several national and international registries, including SANI (Severe Asthma Network Italy), and considering the strong impact that frequent or regular use of oral corticosteroid has on quality of life (QoL) of severe asthmatics, as well as on the costs for managing corticosteroid-related diseases, oral corticosteroid sparing up to withdrawal should be considered a primary outcome in the management of severe asthma. New biologics have clearly demonstrated that this effect is possible, with concomitant reduction in the rate of exacerbations and in symptom control. Then, there is no reason for using so frequently oral corticosteroid before having explored all alternatives currently available for a large part of severe asthmatics. © 2020 The Authors

U2 - 10.1016/j.waojou.2020.100464

DO - 10.1016/j.waojou.2020.100464

M3 - Article

VL - 13

JO - World Allergy Organization Journal

JF - World Allergy Organization Journal

SN - 1939-4551

IS - 10

M1 - 100464

ER -